Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Afaq Sarwar who wrote (4486)	1/13/1998 9:29:00 AM
From: Gene Voss	Respond to of 23519

Afaq: The HVSF claim has no effect on Vivus or its products.HVSF has asked the court to allow them to manufacture their product claliming they are not infringing on any intellectual property belonging to Vivus. Vivus disagrees with this position and will attempt to enforce their patents which HVSF needs to proceed with their product. These patent challenges are common and Vivus is extremely sophisticated on patent issues. HVSF will need to spend alot of time and money if it is to prevail. Vivus is much better positioned for this challenge than HVSF in my opinion. GV